Joel M. Topf, MD FACP Profile picture
Dec 9, 2021 10 tweets 4 min read Read on X
I am going to try to recap my recent grand rounds on race and GFR in a few #tweetorials. Here is the third one. You can find the presentation files and a video of me presenting at pbfluids.com/2021/12/the-ne……… 1/10
In the 1980's the hot idea in nephrology was low protein diets to preserve GFR. The NIH funded a Big Science study to test the theory, the Modification of Diet in Renal Disease study, MDRD. The study was a mess and fell on its face, but they did collect a lot of cool data! 2/10
Among that data was iothalamate clearances which are a really good approximation of GFR. So Andy Levey and friends took those data and combined it with age, gender, and race to come up with the MDRD formula. 3/10 Image
This was the original sin, the place where nephrology started to use race to calculate eGFR. Why did they do it? You can see the from the data that Black people (open circles) tended to have higher Cr for the same GFR. 4/10
And just a year earlier a study had been published showing black people had higher serum creatinine than white people. This study had no idea what people's GFRs were. They just found higher creatinine in Black people. 5/10 Image
MDRD had other problems. It underestimated kidney function in people without kidney disease. This was a big problem when screening people to be kidney donors. It also had few black people and even fewer people with diabetes (and zero people on insulin) 6/10 Image
But the equation business was a good racket and in 2009 Level and Co came back with the CKD-EPI formula which corrected or improved many of the problems with MDRD. 7/10 Image
CKD-EPI is way more complex than previous formulas. It includes a technique called a knot to allow it to change the slope at low creatinines to try to improve accuracy at high GFRs. 8/10
You can see the effect of the knot here, note the decreased bias at GFRs over 60 9/10 Image
With the larger number of Black people the race adjustment shrank by about a quarter from 21% to 16%. Up until September of 2021 this was the formula people were supposed to use but a survey of clinical labs in 2019 found that 60% still used MDRD! 10/10 ImageImage

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Joel M. Topf, MD FACP

Joel M. Topf, MD FACP Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @kidney_boy

Sep 21
Next session started by Rovin to talk about IGAN pathophysiology and the selection of therapeutics

4-hit model
1. formation of IGA galactose deficient
2. formation of autoantibodies against these IgA
3. Formation of circulating IgG-IgA1 immune complexes
4. Deposition of the immune complexes in the kidney

#RKDSummit
1st case
Hematuria on U/A
Gross hematuria after covid vaccine
10 RBC/HPF, no casts
Scar 0.9 mg/dl, 24-hr urine 750 mg of protein

#RKDSummit
Image
Image
A bit “Juicy”
Mesangial expansion (arrows, fig 1)
Mesangial hypercellularity (circle, fig 2)
Biopsy has no chronicity (fig 3)
Lights up with C3 and IgA (fig 4)

#RKDSummit


Image
Image
Image
Image
Read 35 tweets
Sep 21
Honored to be invited to second annual Rare Kidney Disease Scientific Summit. Amazing cast of physicians in attendance. #RKDSummit
Image
Image
Brad Rovin and John Barratt (IGAN king) defend the focus on IgAN and FSGS. Update and recap of the last year. #RKDSummit Image
Agenda look interesting.
Rovin says he is going to call out people from the audience. #RKDSummit Image
Read 21 tweets
Apr 13
When we published our study <> of ODS and hyponatremia we were pummeled for including people at low risk of ODS because we included Na levels between 120 and 130. They said it is well known "that ODS is incredibly rare/non-existent at those levels." 1/4evidence.nejm.org/doi/10.1056/EV…
Of course one of the reasons it was thought to be incredibly rare was that no one looked for CPM in patients with Na from 120-130. We found a fair number (≤5 of 12). 2/4 Image
Our findings are replicated in a study from Australia. The authors took a different approach to investigating ODS. Instead of starting w/ hyponatremia and working forward to ODS, they started with a dx of ODS and worked backwards
3/4ncbi.nlm.nih.gov/pubmed/35717664
Read 4 tweets
Sep 17, 2023
Gadolinium in dialysis patients.
What's up with that?
#Tweetorial
1/11
Nephrogenic systemic fibrosis (NSF) is an iatrogenic disease that presents with hardening of the skin and other organs. It is often lethal. I treated 5 people with this condition (including one with AKI). Terrible.
2/11 Image
The etiology of NSF was unknown and there were many theories. In 2006, Thomas Grobner published a small case series showing 5 patients developing NSF within weeks of receiving gadolinium contrast for MRI.
3/11pubmed.ncbi.nlm.nih.gov/16431890/
Read 12 tweets
Aug 12, 2023
I just recently recommended the Renal Physiology book by Bruce Koeppen and Bruce Stanton. I thought it was a good medical student level text book: pbfluids.com/2023/08/ouwb-s…
But I came across this question in Chapter 8 Regulation of Acid Base. It is a straight forward question asking the learner to interpret simple acid-base cases. Image
But the question falls apart when you look at the answer... Image
Read 7 tweets
Apr 14, 2023
Lab guy from Yale up next Joe El Khoury He is on YouTube. Episode 1 was on pseudohyponatemia
209 subscribers. Clinical Chemistry with Joe El-Khoury Image
Here is the YouTube channel: youtube.com/@ClinChemJoe

https://t.co/LWupt0HWN1 #NKFClinicals
Despite calling it “laboratory error”, a lot of the problem happens long before the sample gets to the lab. #NKFClinicals Image
Read 9 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(